Stage IVA Prostate Cancer AJCC v8 Suspended Phase 2 Trials for Niraparib (DB11793)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04037254Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate CancerTreatment